Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT
Parafilm Application to Prevent Central Line Associated Bloodstream Infections in Pediatric Patients Undergoing Hematopoietic Cell Transplantation
Sponsor: Emory University
Listed as NCT02575079, this NA trial focuses on Bone Marrow Transplant and Central Line Associated Bloodstream Infections (CLABSI) and remains completed. Sponsored by Emory University, it has been updated 12 times since 2015, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Jul 2019 — Jan 2021 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Dec 2018 — Jul 2019 [monthly]
Completed NA
-
Jul 2018 — Dec 2018 [monthly]
Completed NA
-
Jun 2018 — Jul 2018 [monthly]
Completed NA
-
Apr 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
For direct contact, visit the study record on ClinicalTrials.gov .